Know the risk before you run the assay.
Screen compounds against 12 Tox21 toxicity endpoints in seconds. Built for medicinal chemists and drug discovery scientists who need fast, reliable safety predictions.
From academic research to pharmaceutical development — our ChemBERTa-powered models bring the same precision to early-stage compound screening.
Tox21 Endpoints
Screen compounds against 12 nuclear receptor and stress response pathways including NR-AR, NR-AhR, NR-ER, SR-ARE, SR-p53, and more.
ADMET Profiling
Comprehensive drug-likeness analysis with Lipinski Rule of 5, Veber oral bioavailability rules, PAINS alerts, and key molecular descriptors.
Risk Scoring
Weighted composite risk score with Low, Moderate, and High tier classification plus 2D molecular structure visualization.
12
Tox21 Endpoints
<90s
Analysis Time
ADMET
Full Profiling